GlassScriptPhysician profile
Medha Joshi
NPI 1174838916
$909.44
in general payments reported to CMS, 2019-2025
13 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26.51 · 2023: $231 · 2024: $262 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequel Med Tech, LLC | $159.62 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $124.93 | 2024 | |
| Novo Nordisk INC | $121.27 | 2022-2025 | |
| Amgen INC. | $113.51 | 2023 | Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $112.50 | 2024 | |
| Alexion Pharmaceuticals, INC. | $84.22 | 2025 | Strensiq |
| Mannkind Corporation | $78.51 | 2023 | V-Go, Afrezza |
| Dexcom, INC. | $25.92 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $24.87 | 2024 | Freestyle Libre 3 |
| Ascensia Diabetes Care US INC. | $24.11 | 2025 | |
| Medtronic, INC. | $15.55 | 2025 | Inpen Smart Insulin Delivery System |
| Stryker Corporation | $12.72 | 2023 | Infinity Adaptis |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Medha Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.